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1. Introduction
Firms face ever-increasing competition from globalization and e-commerce as their com-
petitors may more easily establish a presence in both domestic and foreign markets. Competi-
tion, in an environment which is generally characterized by global supply chains, strengthens
the importance of innovation in product development as well as efficient production. In this
context innovation often emerges as an outcome of research and development (R&D) activi-
ties and plays a vital role in maintaining firms’ profitability and their competitive edge in a
globalized market.2
It has long been recognized that R&D activities bring additional intangible benefits
which may help firms overcome barriers to exporting.3 In particular, given the availability
of detailed firm-level data on export sales, researchers have begun to investigate the linkages
between R&D expenditures and firms’ export behavior. Yet, this line of research has mostly
focused on the question of whether R&D affects firms’ exports. However, as Harris & Moffat
(2011) suggest, exporting does not require prior R&D innovation. It is also recognized that
exporting firms may access strategic knowledge, as exporting allows them to improve their
innovative capacities.4
In this paper, in contrast to much of the literature, we hypothesize that firms operating
in diversified export markets are more likely to engage in R&D activities. According to
Porter (1990), innovation can help a firm achieve a competitive advantage in international
markets over potential competitors. Kotabe (1990) suggests that multinational firms may
have better access to global resources to enhance their innovative capabilities.5 In particu-
2See Acs & Audretsch (1988), Mairesse & Mohnen (2005).
3See, for instance, Cohen & Levinthal (1989), Teece & Pisano (1998), and Harris & Li (2009).
4See, for example, Bishop & Wiseman (1999) and Blind & Jungmittag (2004).
5Research has also shown that multinational companies are more susceptible to agency costs, as monitor-
ing of such companies is more challenging. Doukas & Pantzalis (2003) document that the effects of agency
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lar, having access to a wider customer base may encourage a firm to innovate via increased
R&D activities, as innovation allows the company to achieve strategic competitiveness. Nev-
ertheless, the literature on the potential association between export market diversification
and R&D activities is meager. To our knowledge, the only study is by Hitt et al. (1997)
which investigates the linkages between innovation and firm performance, focusing on a cross
section of 295 large US firms. They show that an entropy-based measure of international
diversification has a positive effect on R&D intensity, measured as expenditures per employee
(p. 785, Table 3).6 However, most of the papers in this genre focus on the effects of R&D
activities on firm performance rather than the role of export market diversification on R&D
expenditures.7
To investigate the effects of export sales diversification in different export markets on
firms’ R&D activities, measured by the ratio of R&D expenditures to total assets, we con-
struct a large unbalanced panel of UK quoted manufacturing firms obtained from the Extel
Financials database produced by Thomson Financial. The dataset provides us information
on firm-specific variables on an annual basis over 1990–2008 for 19 industry classifications
for which we have 3,880 observations. Our empirical model takes into account several firm-
specific factors including the effects of foreign productive assets, size, leverage, cash holdings,
costs on long term debt are exacerbated by the degree of firms’ foreign involvement (p. 89). Some researchers
suggest global diversification can reduce shareholder wealth (e.g., Denis et al. (2002)), while Doukas & Kan
(2006) argue against this claim.
6Hitt et al. (1997) use averages of the data over 1998–1990 to smooth annual fluctuations in observed
variables; see p. 778.
7Researchers have studied the effects of international diversifications on stock market valuation of firms:
Dos Santos et al. (2008) find that a significant valuation discount applies to product diversification but not
to international diversification. Ursacki & Vertinsky (1992) suggest that multinational banks may benefit
from broadening the geographical scope of their business.
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new equity issuance and cash flow to control for firm heterogeneity.
In examining the role of export sales diversification on R&D expenditures, we specifically
consider the impact of firm-level export sales in different regions of the world. To do this
we construct two diversification measures which are commonly used in the literature: the
Herfindahl–Hirschmann concentration index and an entropy-based index. These two mea-
sures allow us to quantify the market presence of the firm in the rest of the world. Our
dataset includes firm-level exports to four broadly defined regions: Europe, the Americas,
the Middle East and Africa, and Asia and Australia. We calculate firm-specific diversifica-
tion indices for each measure to test our hypothesis that as a firm exports to regions beyond
its home region—i.e., the more diversified is a firm in its export sales—the firm must be
involved in more innovative activities to be competitive in that wider range of markets. In
doing so we expect to find that a UK firm exporting to the rest of the world other than
its home market will increase the scale of its R&D activities, while the firm that focuses on
sales in the home region will not necessarily do so. Our reasoning for this behavior is that a
product that is suitable for the domestic market and those of nearby countries may not be
as attractive to those customers more distant from the domestic market, requiring the firm
to initiate or increase the scale of R&D activities.
In estimating the impact of export market diversification on R&D expenditures, one must
carefully account for the bias that could be introduced due to the presence of zero values
of R&D expenditures as well as that could arise due to endogeneity of the diversification
measure. Our dependent variable, the ratio of R&D expenditures to total assets, is bounded
by zero. Linear regression techniques do not respect that lower bound, nor do they take into
account the likelihood that a firm may not choose to engage in R&D activity. To overcome
these difficulties—the bias that can arise due to the presence of endogenous variables in
our model as well as the presence of zeros—we employ the instrumental variables Tobit
model, estimated by maximum likelihood. We check for the validity of our instruments by
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implementing an overidentification test.
Our empirical findings provide evidence that export market diversification has a positive
impact on R&D activities of firms. More specifically, we find that both the Herfindahl–
Hirschmann concentration index and the entropy-based measure exert a positive and signifi-
cant effect on firms’ R&D expenditures. Our model also shows that the financial strength of a
firm, captured through its stock of cash, net equity issuance, foreign productive assets as well
as its size, positively affect R&D expenditures. To examine the sensitivity of our results, we
implement a battery of additional specifications. We initially show that the use of a dynamic
partial-adjustment framework, allowing R&D expenditures to evolve in a smooth path, does
not alter our findings about the importance of diversification on R&D expenditures.8 We
next entertain the possibility that our results may reflect reverse causality: that is, R&D-
intensive firms may be more diversified in their choice of export markets.9 Our investigation
reveals that there is no evidence of reverse causality. Finally, we subject our findings to two
additional robustness tests. The first specification considers only R&D-intensive firms as
we consider the bidirectional examination of this relationship, and the second specification
separates home (UK) sales from exports to other European markets. Results from these
additional sensitivity checks provide further support to our hypothesis that diversification
induces firms to carry our more R&D expenditures.
The rest of the paper is organized as follows. Section 2 briefly reviews the literature.
Section 3 presents the model and describes our data. Section 4 provides the empirical
results and Section 5 concludes.
8See for instance Hall, Bronwyn H. (2002) and Hall, Bronwyn H. & Lerner, Josh (2009) who argue that
firms’ R&D expenditures are smoothed to maintain their stability.
9There is significant research that examines the role of R&D expenditures on exports which has shown
that R&D expenditures facilitate firms’ entry into export markets. See Harris & Moffat (2011) for an
extensive review of this literature.
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2. Literature Review
It is well documented in the literature that in an imperfectly competitive market, an
R&D–active firm can innovate, increase its productivity and gain a competitive edge over
its rivals in the domestic and foreign markets.10 As detailed data on firm-level exports
and R&D expenditures have became available, empirical researchers have provided more
detailed account of the linkages between R&D expenditures, productivity and exports. For
instance, researchers using data from several countries, including Sterlacchini (2001), Bleaney
&Wakelin (2002), Barrios et al. (2003), Ozcelik & Taymaz (2004), Roper et al. (2006), Girma
et al. (2008), and Harris & Li (2009), investigate whether R&D expenditures facilitate firms’
entry into export markets. The conclusion of this strand of literature is that firms that are
heavily involved in R&D activities are more likely to be exporters.11
It is equally important to recognize the possibility that more vigorous competition and
differing consumer preferences in foreign markets may induce firms to carry out R&D activ-
ities so that they can improve their innovative capabilities and stay ahead of their rivals: i.e.
the so called learning by exporting hypothesis.12 However, there is only a handful of studies
that evaluate this hypothesis. Clerides et al. (1998) argue that the stochastic processes that
generate cost and productivity trajectories should improve with changes in exporting status
if learning-by-exporting plays an important role. They provide evidence using data from
Mexico, Colombia and Morocco. Salomon & Shaver (2005) and Aw et al. (2007) recognize
that learning-by-exporting can lead to increased innovation. Girma et al. (2008) investigate
10See along these lines Acs & Audretsch (1988), Cohen & Levinthal (1989), Cohen & Levinthal (1990),
Teece & Pisano (1998), Mairesse & Mohnen (2005).
11The empirical literature cited above base their investigation on analytical models such as those developed
by Posner (1961), Krugman (1979), Dollar (1986), Greenhalgh et al. (1994), Grossman & Helpman (1995).
12See Greenaway & Kneller (2007) and Wagner (2005) for a survey of the productivity and exports liter-
ature.
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the bidirectional relationship between R&D and export activity and finds that while previ-
ous exporting experience enhances the innovative capability of Irish firms, this is not true
for the British firms in their sample. Hall et al. (2009) show that enhanced international
competition leads to higher levels of R&D, while Damijan et al. (2010) find that exporting
influences innovation. More recently, Aw et al. (2011) develop a dynamic framework to
model exporting and R&D and show that current R&D directly impacts the probability of
exporting, while current exporting alters the return to R&D. They present evidence that
exporting enhances productivity, while exporting firms invest more in R&D.
Following this line of reasoning, we argue that learning-by-exporting becomes even more
crucial for firms exporting to countries further distant from their home markets, as they will
face more competitive pressures and different consumer preferences.13 We expect that as
firms expand their export markets to different regions then their own, they may devote more
resources to innovation in the form of R&D expenditures. Along these lines, Hitt et al. (1997)
focus on a cross section of 295 large US firms and show that international diversification has
a positive effect on R&D intensity (p. 785, Table 2).14 Yet, to our knowledge, there are no
other studies that explore the importance of diversification of export markets on the firm’s
R&D activities, as most of the research in this genre focuses on the effects of diversification
on firm performance.
2.1. Methodological Issues
An important methodological issue arises when considering the modeling of our dependent
variable, the ratio of R&D expenditures to total assets (TA), which is bounded from below.
In any sample of firm-level data, it is likely that a number of firms will report zero values
13It is equally possible as Kotabe (1990) suggests that diversified firms have easier access to financial
resources allowing them to smooth their R&D expenditures.
14Also see Van Biesebroeck (2005) and De Loecker (2007) who find that productivity increases after firms
enter the export market in Ivory Coast and Slovenia, respectively.
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for this category of expenditure in a given year. However, in a standard regression context,
the empirical distribution of the series due to the prevalence of zero values is neglected.
In confronting this issue, some authors (e.g., Czarnitzki & Toole (2011)) have made use of
censored normal regression techniques such as the Tobit model. In our empirical investigation
we, too, make extensive use of the Tobit model.
The second difficulty in estimating the effects of diversification on R&D expenditures is
the endogeneity problem. Firms’ decisions to begin selling overseas and to innovate could
be made simultaneously, as they might face a positive demand shock which leads to both
expansion into new markets and an increase in their R&D investment. In this case we face
the crucial problem of endogeneity which leads to biased estimates, as some explanatory
variables are not orthogonal to the error process. We employ two approaches to address this
important issue. First, we make use of the instrumental variables maximum likelihood Tobit
estimator (Miranda & Rabe-Hesketh (2006)), employing second and third lags of endogenous
variables as instruments. The validity of these instruments is gauged by an overidentification
test. Second, we consider reverse causality as a robustness check, and reestimate the model
using the diversification measure as the dependent variable.15
3. Empirical Implementation
3.1. Test Design
To analyze the link between firms’ R&D intensity and their geographical diversification
of export sales, we use the following econometric specification:
RD/TAi,t = α0 + α1Diversificationi,t−1 + α2ForeignAssetsi,t−1
15In a standard instrumental variables linear regression, such an approach would be unnecessary, as nor-
malization of the relationship is arbitrary. In the context of the instrumental variables Tobit likelihood
function, that principle does not apply. As a significant fraction of firm-years have diversification measures
equalling zero, estimation of a Tobit model in this context is appropriate.
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+ α3NewEquityi,t−1 + α4 log(Employment)i,t−1 + α5Debt/TAi,t−1 (1)
+ α6Cash/TAi,t−1 +
J∑
j=1
βjDevi,t−1 + µj + τt + ǫi,t
where i indexes the firm, j the industry, and t the year. Our dependent variable is RD/TAi,t,
the ratio of research and development expenses to beginning-of-period total assets. It is useful
to note at this junction that some researchers have measured R&D intensity relative to sales,
rather than total assets, but this latter measure may be unduly sensitive to variations in
demand which have little to do with the intensity of research efforts.
The key coefficient of interest is α1, which determines the response of R&D expenditures
to Diversificationi,t−1, a measure of geographical sales diversification in the previous year.
To test the hypothesis that firms that have access to diversified export markets are more
R&D-active, we use two different diversification indices constructed using information on
firms’ export sales to four regions: Europe; America; Middle East and Africa; and Asia and
Australia. Our first export diversification measure is a transformation of the well-known
Herfindahl–Hirschmann concentration index:
Diversification HHIit = 1−
n∑
r=1
x2r,i,t
Given the above definition and the regions where UK firms export, the values of our diver-
sification measure will be within the [0.0, 0.75] interval for each firm. When this measure
equals zero, HHI equals one, as that company sells only to the European market. The highest
possible value of this measure is 0.75, which corresponds to a HHI of 0.25, representing equal
sales in each region. Our second diversification measure is entropy-based and quantifies the
expected value of the information contained in a specific realization of the random variable.16
16See Shannon (1948) for more along these lines. Note that Hitt et al. (1997) also implement this measure.
10
The measure takes the following form:
Diversification Entropyit = −
n∑
r=1
xr,i,t log(xr,i,t)
where in the case of xr,i,t = 0 for some i and t, the value of the corresponding term is
taken to be 0, which is consistent with the well-known limit that limp→0+(p log p) = 0. The
upper bound is attained when a firm exports evenly to all regions. Therefore, this measure
will be bounded within the [0.0, log(4)] interval. We should note that although these two
diversification measures are expected to be correlated, they represent different approaches
in forming a scalar measure of the firm’s export sales diversification.
Given that our data are comprised of UK firms, their domestic sales are naturally included
in sales in the European region, so that a firm with purely domestic sales would still be classed
as selling in Europe even if they had no export sales. Even though a UK-based firm that
exports to other European markets may be subject to exchange rate risk, foreign income risk,
and the like, it will be considered as undiversified given the definition of our diversification
measure. In our empirical models, to account for the volatility that is expected to arise due to
fluctuations in cash flows, we use two different risk measures as discussed below.17 Separately,
as our dataset provides information on domestic sales, we can calculate the amount of exports
to European markets as the difference between recorded sales to the European region and
the UK. However, because measurement error introduced by this calculation may weaken
our inference, we consider this further distinction only as a robustness check rather than
implementing it throughout the empirical analysis.
17We do not introduce a measure to proxy for exchange rate volatility in our model as R&D expenditures
are related to long term projects; short-term variations in the exchange rate should not affect our results.
To establish robustness, we compute a measure of exchange rate volatility based on trade-weighted real
exchange rate data and introduce it into the model in place of the year dummies. The results show that the
coefficient on this exchange rate volatility measure is not significant.
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Our model contains several variables as controls in the estimated equation. As a firm’s
presence in foreign markets may also be represented by its foreign direct investment (FDI),
we include ForeignAssets, a binary variable equal to one if the firm reports the ownership
of foreign productive assets that year. Next, we incorporate three control variables into
the model which are commonly used in the literature: firm size, computed as the natural
logarithm of the number of employees (log(Employmenti,t)); leverage, measured as the ratio
of last period’s total debt to total assets (Debt/TAi,t−1); and liquidity, calculated as the ratio
of last period’s cash and equivalents to total assets (Cash/TAi,t−1).
18 We also make use of
the ratio of last period’s new equity issuance to total assets (NE/TAi,t−1). Throughout our
investigation, to reduce the bias caused by simultaneity in firms’ financial decisions with
R&D expenditure decisions, we make use of lagged values of leverage, liquidity and new
equity issuance rather than their contemporaneous observations.19
Firms’ decisions to invest in research and development activities are subject to both
common and idiosyncratic shocks. To account for these factors, we augment Equation (1)
with a set of industry indicator variables (µj) and interactions of those indicator variables
with a measure of firm deviations, Devi,t. These deviations, computed for the ratio of
last period’s cash flow to total assets (CF/TAi,t−1), capture firm-specific or industry-wide
deviations of the firm’s inflow of funds. The first measure, which captures the deviation of
expected cash flow from the observed value, is based upon a panel data AR(1) regression:
CF/TAi,t = γ0 + γ1CF/TAi,t−1 + νi + ξi,t
where νi is a firm fixed effect. The sequence of residuals from this regression, ξˆi,t, are
18We have also interacted the diversification measures with industry dummies and obtained qualitatively
similar results.
19Results when we use contemporaneous observations are similar to those we report in our tables and are
available upon request.
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employed as the firm deviation measure Devi,t. These residuals may be viewed as in-sample
forecast errors in forecasting the cash flow ratio for that firm. More concretely, we define
the firm deviation as
Devfit = CF/TAi,t − (γˆ0 + γˆ1CF/TAi,t−1 + νˆi)
This measure acts as a proxy for the extent of uncertainty that the firm faces with respect
to its inflow of funds.20
The second proxy measures the degree to which the firm’s cash flow ratio diverges from
that of its industry, defined as:
Devindit = CF/TAi,t −
˜CF/TAi,t
where ˜CF/TAi,t is the median value of CF/TAi,t for all firms in industry j at time t. This
deviation measure reflects how the firm’s value of their cash flow to total assets ratio differs
in that year from the industry median.21
Our model, Equation (1), also includes a full set of time fixed effects (τt). Finally, ǫit is
an idiosyncratic error term.
3.2. Data
In our empirical analysis, we use an unbalanced panel extracted from the Extel Finan-
cials database produced by Thomson Financial. Our estimation sample is compiled in the
following way. We first dropped observations corresponding to service industries and those
firms who had fewer than five years of coverage. We also removed firm-years with incomplete
20We also experimented with a firm-specific AR(1) model for CF/TA. The results from this set are
qualitatively similar and we choose not to report them for brevity.
21Using both definitions, we also considered three alternatives to the ratio of CF/TA: the ratio of sales
to total assets, cash to total assets, and sales per employee. Results were broadly similar to those produced
by CF/TA as reported here.
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sales data. Our resulting sample consists of a panel of about 3,880 firm-year observations
pertaining to 795 companies over the period from 1990–2008 for 19 industry classifications.
We winsorized variables in the model at the 5 and 95 percent thresholds.22
Descriptive statistics for the firm-year observations entering the analysis are presented
in Table 1. Average R&D spending is about 2% of the assets but highly skewed towards
the top end. Average export sales diversification is about 23%, increasing to 32% when
five regions are considered. It appears that many firms are involved in exporting as the
median figure stands at 19% and the third quartile is at 47%. Interestingly, half of the firms
in the dataset report the presence of foreign productive assets in their capital stock. The
descriptive statistics also show that firm size varies considerably less than firms’ liquidity
and debt ratios. Finally, we see that only a quarter of firms raise funds through the equity
markets.
4. Empirical Results
We estimate Equation (1) for several alternative specifications for the full sample, in-
cluding either firm-specific or industry-level deviations of firms’ cash flow ratios: deviations
obtained from the panel data AR model or those from the industry median. The foot of each
table presents the Firm Deviations p-value which corresponds to the test for the joint signif-
icance of the coefficients associated with the deviations of cash flow, interacted with each of
the 19 industry indicator variables. For brevity, these 19 coefficients are not reported in the
tables.23 Note that both measures of cash flow deviations are jointly significant for most of
the models at the 5% level or better and their effect significantly varies across industries, as
verified by the p-value of the test for their joint significance. Given this initial observation, in
what follows we focus on the impact of diversification on R&D expenditures and the remain-
22We also experimented with less restrictive thresholds and obtained qualitatively similar results.
23Expanded results are available on request.
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ing control variables. All models are estimated by implementing the instrumental variables
Tobit estimator, where we instrument the endogenous variable with its lags. We test the
validity of our instrument set with an overidentification test and show that our instruments
are valid and the model is properly specified. The last row of each table provides the p-value
of that χ2 test statistic. Hence, we make no further comments along these lines as we discuss
our estimates.
4.1. Export market diversification: Basic model
Table 2 presents estimates of Equation (1). The results presented in Columns 1 and 3
are obtained using the Herfindahl-based diversification index and those in Columns 2 and 4
are based on the entropy-based diversification index. The results in the first two columns are
obtained when we measure the firms’ cash flow deviations from their expected value, while
the results in columns 3 and 4 result from measuring the firms’ cash flow deviations from the
industry average. We expect a priori that the coefficient of diversification will be significant
and positive if our hypothesis should receive support from the data. Indeed, looking at the
table, we see that the Tobit estimates provide strong evidence in support of our hypothesis:
export market diversification has a positive impact on R&D expenditures for the UK firms
regardless of the diversification index used. These estimates suggest that a one standard
deviation increase in diversification leads to an 0.41% increase in R&D activities. Given
that the average of R&D expenditures to total assets ratio is on the order of 2%, this is a
significant change.
Next we explore the role that control variables play in the model. We observe that firm
size, captured by employment, also has a positive impact on firms’ R&D spending. That is,
larger firms spend relatively more on R&D expenditures as a fraction of their total assets
than do their smaller counterparts. Although firms’ ownership of foreign productive assets
15
has a positive effect on R&D expenditures, this impact is not significant.24
It is well accepted that the financing of R&D capital is mostly hindered by its intangible
nature, rendering it unavailable as collateral. As many studies have shown, this causes
the funding of R&D expenditures to be more dependent on internal funds than capital
expenditures on plant and equipment.25 In this respect ‘pecking order’ theories have shown
that new equity issuance is a higher-cost source of funds due to high fixed costs, such as
underwriting fees, and its dilution of shareholder wealth. To this end, the sizable coefficients
on cash holdings in the results described above highlight the importance of a firm’s cash
buffer in supporting their R&D expenditures. Here, we also observe that the firm’s debt
burden impedes R&D expenditures as expected. These results are not surprising: (i) R&D
investment contributes to the stock of intangible capital and cannot be used as collateral;
and (ii) R&D expenditures have a lengthy and highly uncertain payback.
In our investigation, we also consider the findings of Brown et al. (2009) and Carpenter
& Petersen (2002) as we evaluate whether new equity issuance plays an important role, over
and above the effects of leverage and cash holdings. This is reasonable, as financing R&D
activities through the issuance of equity may be particularly important for those firms that
are severely restricted due to inadequate internal funds. Table 2 provides evidence that new
equity sales have a positive impact on UK firms’ R&D expenditures.
4.2. Robustness Checks
In this section, we implement several different specifications to check for the model’s sen-
sitivity to certain alternative specifications. In what follows, we examine (i) the persistence
in R&D expenditures by introducing the lagged dependent variable in the basic specifica-
24The dataset does not provide information as to where the R&D activities are carried out. Though it
would be interesting to examine factors that promote home versus foreign R&D activities as data become
available, our main concern is the behavior of firms’ total R&D expenditures.
25For an overview of this literature, see Baum et al. (2013).
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tion; (ii) the possibility of reverse causality; (iii) the subset of positive R&D firms as we
scrutinize both directions of causality; and (iv) separating domestic sales from exports to
other European markets.
4.3. Dynamics and Export Market Diversification
In this subsection we introduce the lagged dependent variable into Equation (1) to con-
sider the persistence of R&D expenditures. As Hall, Bronwyn H. & Lerner, Josh (2009)
stress (p. 5), a multi-year purchase of machinery could be rescheduled in the face of financial
exigencies, but it would be much more difficult to temporarily reduce R&D expenditures.
They indicate that this is perhaps the most important distinguishing characteristic of R&D
investment, and leads to firms’ smoothing R&D spending over time so that they may retain
their skilled human capital.
In the context of instrumental variables Tobit modeling, adding the lagged dependent
variable to capture the smooth behavior of R&D expenditures leads to a downward bias in
the estimates (see Greene (2004)). However, this bias is likely to decline as the time series
dimension of the panel increases. Given that most firms in our data have a reasonably long
time series (1990–2008), the effect of this bias can be expected to be minimal. Furthermore,
we should note that our results could be expected to be even stronger if bias-corrected esti-
mates could be computed.26 The results for such a model where we add the lagged dependent
variable are given in Table 3. Notice that the coefficient of the lagged dependent variable
is positive and significant, suggesting that those firms that are involved in R&D activities
in the previous period tend to continue their R&D programme in subsequent periods. How-
ever, the extent of persistence does not seem to be high, as the coefficient is on the order of
26We have also experimented by estimating the dynamic specification by employing the Wooldridge (2005)
approach. Unfortunately, in most cases we encountered convergence problems. As a consequence we pro-
ceeded with standard instrumental variable Tobit results.
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0.44–0.45.
When we focus on the coefficient of the diversification index, regardless of the measure
used, we find that it has a positive sign for both panel and industry based cash flow devi-
ations. Given the coefficient estimates, the long run effect of diversification for the model
in column 1 can be calculated around 1.3%: a figure not significantly different from that in
Table 2. Similar observations are valid for the other columns. We consider that this provides
meaningful support for our claim that diversified export markets induce firms to engage in
R&D activities.
When we inspect the remaining coefficient estimates, we find results similar to those in
Table 2, except that the coefficient of cash to total assets is positive but no longer significant.
The ratio of debt to total assets has a negative but insignificant impact on R&D activities.
4.4. Exploring the Possibility of Reverse Causality from R&D Expenditures to
Export Diversification
Given that earlier research has shown that investment in R&D facilitates firms’ entry into
export markets, it is important to consider if the results that we have shown so far are the
consequence of a feedback effect due to reverse causality. Hence, we examine the following
instrumental variables Tobit model to explore this possibility:
Diversificationi,t = γ0 + γ1RD/TAi,t−1 + γ2ForeignAssetsi,t−1
+ γ3NewEquityi,t−1 + γ4 log(Employment)i,t−1 + γ5Debt/TAi,t−1
+ γ6Cash/TAi,t−1 +
J∑
j=1
ζjDevi,t−1 + µj + τt + ǫi,t (2)
where we use the same control variables and instrument structure as in our main results.
Results for this model are given in Table 4. Looking at the first row of the table we see that
R&D expenditures has a positive but insignificant effect on firms’ export diversification.
This observation holds for both diversification measures. Based on the findings reported
in Table 4, there is no empirical support for reverse causality from R&D expenditures to
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export diversification. Turning to the control variables, we observe that lagged foreign assets,
firm size as captured by log of employment, debt ratio and cash stock have a positive and
significant impact on diversification, yet new equity has no significant effect.
4.5. Focusing on Positive R&D firms only
The next two robustness checks focus only on positive R&D expenditure firms as we
again examine bidirectional causality.27 Table 5 presents results for Equation (1) estimated
for only those firms with positive R&D investment. Using this subsample, we then examine
the possibility of reverse causality given in Equation (2) and report regression results in
Table 6.
Focusing first on the results presented in Table 5, we see that the coefficients associated
with both diversification measures are positive and significant. In fact, these coefficient
estimates are even greater than what we reported in Table 2 earlier, as we would expect
in this selected subsample. When we turn to control variables, we see that while the cash-
to-assets ratio has a positive and significant impact on R&D activities, net equity issuance
does not appear to exert any significant effects. Furthermore, debt and foreign productive
assets do not play significant roles in R&D expenditures for R&D-active firms. However, the
coefficient of firm size is negative and significant, implying that smaller R&D-active firms
make a greater effort to diversify. This observation is sensible, as small, innovative firms tend
to expand into new markets as they strive to take advantage of the unique characteristics of
their products.
When we consider Table 6, once again we find no evidence of reverse causality. R&D
expenditures do not appear to have any significant impact on diversification. Turning to
firm-specific variables, we observe that foreign productive assets, firm size and cash stock
27We do not consider this restricted sample in the main results of our paper as the restriction introduces
the possibility of selection bias: an issue that is avoided by including zero-R&D firms in the main analysis.
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have a positive and significant impact on diversification, while the remaining variables have
no significant effects.
4.6. Europe as a Separate Region
The original sample provides information on exports of UK firms to four regions: Europe,
the Americas, the Middle East and Africa, and Asia and Australia. In this dataset, domestic
(UK) sales are aggregated into exports to Europe. Separately, the dataset provides sales in
the home market (UK) only. Hence, it may be possible to extract information on exports
to European destinations only, as we can remove the firm’s UK sales from exports to the
European region. This is straightforward, but raises a potential problem of measurement
error. Thus, we present these imputed intra-European sales only as a robustness check.
Given this finer classification of sales destinations, we recompute measures of diversification
for five regions: the UK, Europe excluding UK sales, the Americas, the Middle East and
Africa, and Asia and Australia, and present the results in Table 7. In this set of results,
regardless of the measure used, we observe that diversification has a positive impact on
R&D expenditures. Furthermore, the control variables play a similar role as discussed in
Table 2. Overall, we conclude that those results in Table 7, along with those we presented
earlier, support our hypothesis that sales diversification induces firms to carry our more
R&D activities.
5. Conclusions
Researchers have been investigating various factors that induce firms to carry out R&D
activities. However, this literature has not provided a rigorous study on the importance of
export market diversification on R&D expenditures. In this paper we empirically scrutinize
the impact of export market diversification on R&D expenditures in a panel of UK manufac-
turing firms. In estimating the impact of export market diversification on R&D expenditures,
we account for the bias that could be introduced due to the presence of zero values of R&D
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expenditures as well as that could arise due to endogeneity of the diversification variable.
Hence, we implement instrumental variables techniques in the context of the Tobit model.
We check for the validity of our instruments and show that our models are properly specified
and the instruments are valid.
Our empirical model controls for several firm-specific variables which are shown to be im-
portant in the literature, including foreign productive assets, firm size, leverage, liquidity, as
well as new equity issuance. Finally, we compute and separately incorporate two different risk
measures based on firm-specific or industry cash-flow deviations, because export-diversified
firms may face fluctuations in their cash flows which could in turn affect their R&D activities.
We carry out our analysis using a large unbalanced panel of UK quoted manufacturing
firms obtained from the Extel Financials database produced by Thomson Financial. The
database provides us information on firm-specific variables on an annual basis over 1990–
2008 for 19 industry classifications, for which we have firm level export data on four broadly
defined regions. Given this information, we compute two different export sales diversification
measures, one based on the Herfindahl–Hirschmann concentration index, and the other an
entropy-based index, to seek support for our hypothesis from the data.
Our results provide strong evidence that a higher degree of export market diversification
induces firms to initiate (or increase the scale of) their R&D expenditures. That is, as
firms export their products to more distant markets, they require greater R&D investment
to remain competitive in the global markets. These findings support the view that firms
selling to a broader range of markets must be more innovative if they are to maintain a
competitive edge over their rivals. To check the robustness of our claim, we estimate several
additional specifications considering (i) persistence in R&D expenditures; (ii) the possibility
of reverse causality; (iii) the subset of positive R&D firms, as we scrutinize for both directions
of causality; and (iv) a finer classification of diversification, as we separate European sales
of firms into UK and non-UK markets.
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For future research it would be useful to expand this analysis to other countries. For
instance it would be interesting the test the importance of export market diversification for
Japan and Germany, both of which have an important presence in world export markets.
Likewise, a similar investigation for China, South Korea, Thailand and Taiwan would be
illuminating, as it would allow one to consider whether these countries can continue to
expand their exports and GDP, as many argue that technological development is the main
engine of growth.
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Table 1: Descriptive statistics, 1990–2008.
Mean SD Q1 Q2 Q3 N
R&D Expenditures/Total Assets 0.02 0.05 0.00 0.00 0.02 3,880
HHI Diversification (4 regions) 0.23 0.23 0.00 0.19 0.47 3,880
HHI Diversification (5 regions) 0.32 0.26 0.00 0.38 0.55 3,880
Entropy Diversification (4 regions) 0.37 0.37 0.00 0.35 0.68 3,880
Entropy Diversification (5 regions) 0.54 0.44 0.00 0.60 0.93 3,880
Foreign Productive Assets 0.52 0.50 0.00 1.00 1.00 3,880
New Equity/Total Assets 0.08 0.20 0.00 0.00 0.05 3,880
log(Employment) 7.46 2.32 6.09 7.45 8.94 3,880
Total Debt/Total Assets 0.20 0.14 0.09 0.19 0.27 3,880
Cash/Total Assets 0.11 0.10 0.03 0.07 0.15 3,880
Notes: Q1, Q2, and Q3 are the first, second and third quartiles, respectively. N is
the number of firm-years. R&D/TA is the ratio of R&D expenditures to total assets.
HHI Sales Diversification is one minus sum of squared shares of sales to four (or
five) regions of the world. Entropy Sales Diversification is entropy based measure of
diversification as discussed in Section 3. Foreign Productive Assets is a dummy variable
equal to one if a firm reports ownership of foreign productive assets and zero otherwise.
New Equity/Total Assets is the ratio of new equity issue to total assets. log(Employment)
is the natural logarithm of the number of employees. Total Debt/Total Assets is the ratio
of total debt to total assets. Cash/Total Assets is the ratio of cash and equivalents to total
assets.
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Table 2: IV Tobit Results, basic specification.
Panel Data Firm–Industry
Forecast Errors Median Deviations
(1) (2) (3) (4)
HHI Sales Diversificationt−1 0.018*** 0.016***
(0.006) (0.006)
Entropy Sales Diversificationt−1 0.011*** 0.010***
(0.004) (0.004)
Foreign Productive Assetst−1 0.003 0.003 0.003 0.003
(0.002) (0.002) (0.002) (0.002)
(New Equity/Total Assets)t−1 0.018** 0.018** 0.018** 0.018**
(0.009) (0.009) (0.008) (0.008)
Log(Employment)t−1 0.001** 0.001** 0.001** 0.001**
(0.001) (0.001) (0.001) (0.001)
(Total Debt/Total Assets)t−1 -0.013** -0.012* -0.011 -0.010
(0.007) (0.007) (0.007) (0.007)
(Cash/Total Assets)t−1 0.023* 0.023* 0.024* 0.025**
(0.012) (0.012) (0.012) (0.012)
Firm-years 1,980 1,980 2,001 2,001
Firm deviations p-value 0.000 0.000 0.002 0.002
Overid p-value 0.134 0.179 0.064 0.092
Notes: Average marginal effects of the regressors on the expected value of the cen-
sored dependent variable are reported. The ratio of R&D expenditures to total assets,
R&D/TA, is the dependent variable. HHI Sales Diversification is one minus sum of
squared shares of sales to four regions of the world. Entropy Sales Diversification is en-
tropy based measure of diversification as discussed in Section 3. Foreign Productive Assets
is a dummy variable equal to one if a firm reports ownership of foreign productive
assets and zero otherwise. New Equity/Total Assets is the ratio of new equity issue
to total assets. log(Employment) is the natural logarithm of the number of employees.
Total Debt/Total Assets is the ratio of total debt to total assets. Cash/Total Assets is the
ratio of cash and equivalents to total assets. Firm deviations is the test of joint significance
of industry dummy variables interacted with panel data forecast errors (p-value reported).
Cluster-robust standard errors (by firm) in parentheses. * p≤ 0.10, ** p≤ 0.05, *** p≤ 0.01.
A constant, time dummy variables, and panel data forecast errors (firm–industry median
deviations) interacted with industry dummy variables are included but not reported in
specifications 1 and 2 (3 and 4). Overid is the test of overidentifying restrictions, p-value
reported.
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Table 3: IV Tobit Results, dynamic specification.
Panel Data Firm–Industry
Forecast Errors Median Deviations
HHI Sales Diversificationt−1 0.007** 0.006**
(0.003) (0.003)
Entropy Sales Diversificationt−1 0.005*** 0.004**
(0.002) (0.002)
(R&D/Total Assets)t−1 0.449*** 0.449*** 0.444*** 0.444***
(0.027) (0.027) (0.026) (0.026)
Foreign Productive Assetst−1 0.000 0.000 0.000 0.000
(0.001) (0.001) (0.001) (0.001)
(New Equity/Total Assets)t−1 0.016** 0.016** 0.020*** 0.020***
(0.006) (0.006) (0.007) (0.007)
Log(Employment)t−1 0.001*** 0.001*** 0.001*** 0.001***
(0.000) (0.000) (0.000) (0.000)
(Total Debt/Total Assets)t−1 -0.003 -0.003 -0.001 -0.000
(0.004) (0.004) (0.004) (0.004)
(Cash/Total Assets)t−1 0.004 0.004 0.005 0.005
(0.005) (0.005) (0.005) (0.005)
Firm-years 1,980 1,980 2,001 2,001
Firm deviations p-value 0.000 0.000 0.000 0.000
Overid p-value 0.156 0.234 0.090 0.136
Notes: Average marginal effects of the regressors on the expected value of the cen-
sored dependent variable are reported. The ratio of R&D expenditures to total assets,
R&D/TA, is the dependent variable. HHI Sales Diversification is one minus sum of
squared shares of sales to four regions of the world. Entropy Sales Diversification is en-
tropy based measure of diversification as discussed in Section 3. Foreign Productive Assets
is a dummy variable equal to one if a firm reports ownership of foreign productive
assets and zero otherwise. New Equity/Total Assets is the ratio of new equity issue
to total assets. log(Employment) is the natural logarithm of the number of employees.
Total Debt/Total Assets is the ratio of total debt to total assets. Cash/Total Assets is the
ratio of cash and equivalents to total assets. Firm deviations is the test of joint significance
of industry dummy variables interacted with panel data forecast errors (p-value reported).
Cluster-robust standard errors (by firm) in parentheses. * p≤ 0.10, ** p≤ 0.05, *** p≤ 0.01.
A constant, time dummy variables, and panel data forecast errors (firm–industry median
deviations) interacted with industry dummy variables are included but not reported in
specifications 1 and 2 (3 and 4). Overid is the test of overidentifying restrictions, p-value
reported.
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Table 4: IV Tobit Results, reverse causality.
Panel Data Firm–Industry
Forecast Errors Median Deviations
HHI Entropy HHI Entropy
(1) (2) (3) (4)
(R&D/Total Assets)t−1 0.208 0.143 0.250 0.165
(0.368) (0.357) (0.577) (0.559)
Foreign Productive Assetst−1 0.264*** 0.256*** 0.421*** 0.411***
(0.018) (0.017) (0.029) (0.028)
(New Equity/Total Assets)t−1 -0.070 -0.023 -0.098 -0.026
(0.043) (0.041) (0.069) (0.063)
Log(Employment)t−1 0.043*** 0.042*** 0.069*** 0.067***
(0.005) (0.005) (0.008) (0.008)
(Total Debt/Total Assets)t−1 0.130** 0.166*** 0.150* 0.205**
(0.053) (0.055) (0.087) (0.088)
(Cash/Total Assets)t−1 0.153** 0.156*** 0.221** 0.225**
(0.063) (0.059) (0.103) (0.098)
Firm-years 1,980 2,001 1,980 2,001
Firm deviations p-value 0.096 0.000 0.151 0.000
Overid p-value 0.245 0.138 0.309 0.196
Notes: Average marginal effects of the regressors on the expected value of the
censored dependent variable are reported. The HHI Sales Diversification and
Entropy Sales Diversification measures are the dependent variables. R&D/TA is the
ratio of R&D expenditures to total assets. Foreign Productive Assets is a dummy variable
equal to one if a firm reports ownership of foreign productive assets and zero otherwise.
New Equity/Total Assets is the ratio of new equity issue to total assets. log(Employment)
is the natural logarithm of the number of employees. Total Debt/Total Assets is the ratio
of total debt to total assets. Cash/Total Assets is the ratio of cash and equivalents to
total assets. Firm deviations is the test of joint significance of industry dummy variables
interacted with panel data forecast errors (p-value reported). Cluster-robust standard errors
(by firm) in parentheses. * p≤ 0.10, ** p≤ 0.05, *** p≤ 0.01. A constant, time dummy
variables, and panel data forecast errors (firm–industry median deviations) interacted with
industry dummy variables are included but not reported in specifications 1 and 2 (3 and 4).
Overid is the test of overidentifying restrictions, p-value reported.
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Table 5: IV Tobit Results, positive R&D firms.
Panel Data Firm–Industry
Forecast Errors Median Deviations
(1) (2) (3) (4)
HHI Sales Diversificationt−1 0.027*** 0.025***
(0.008) (0.008)
Foreign Productive Assetst−1 -0.002 -0.002 -0.002 -0.002
(0.004) (0.003) (0.003) (0.003)
(New Equity/Total Assets)t−1 0.018 0.018 0.019 0.018
(0.014) (0.014) (0.012) (0.012)
Log(Employment)t−1 -0.002** -0.002** -0.002** -0.002**
(0.001) (0.001) (0.001) (0.001)
(Total Debt/Total Assets)t−1 -0.014 -0.013 -0.013 -0.011
(0.009) (0.009) (0.009) (0.010)
(Cash/Total Assets)t−1 0.034* 0.035* 0.036* 0.037*
(0.021) (0.020) (0.020) (0.020)
Entropy Sales Diversificationt−1 0.017*** 0.016***
(0.005) (0.005)
Firm-years 1,273 1,273 1,284 1,284
Firm deviations p-value 0.000 0.000 0.000 0.000
Overid p-value 0.134 0.179 0.064 0.092
Notes: Average marginal effects of the regressors on the expected value of the cen-
sored dependent variable are reported. The ratio of R&D expenditures to total assets,
R&D/TA, is the dependent variable. HHI Sales Diversification is one minus sum of
squared shares of sales to four regions of the world. Entropy Sales Diversification is en-
tropy based measure of diversification as discussed in Section 3. Foreign Productive Assets
is a dummy variable equal to one if a firm reports ownership of foreign productive
assets and zero otherwise. New Equity/Total Assets is the ratio of new equity issue
to total assets. log(Employment) is the natural logarithm of the number of employees.
Total Debt/Total Assets is the ratio of total debt to total assets. Cash/Total Assets is the
ratio of cash and equivalents to total assets. Firm deviations is the test of joint significance
of industry dummy variables interacted with panel data forecast errors (p-value reported).
Cluster-robust standard errors (by firm) in parentheses. * p≤ 0.10, ** p≤ 0.05, *** p≤ 0.01.
A constant, time dummy variables, and panel data forecast errors (firm–industry median
deviations) interacted with industry dummy variables are included but not reported in
specifications 1 and 2 (3 and 4). Overid is the test of overidentifying restrictions, p-value
reported.
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Table 6: IV Tobit Results, reverse causality, positive R&D firms.
Panel Data Firm–Industry
Forecast Errors Median Deviations
HHI Entropy HHI Entropy
(1) (2) (3) (4)
(RD/Total Assets)t−1 0.160 0.142 0.170 0.149
(0.443) (0.432) (0.688) (0.674)
Foreign Productive Assetst−1 0.287*** 0.273*** 0.465*** 0.446***
(0.030) (0.029) (0.048) (0.046)
(New Equity/Total Assets)t−1 -0.056 -0.034 -0.069 -0.035
(0.052) (0.049) (0.080) (0.074)
Log(Employment)t−1 0.053*** 0.054*** 0.084*** 0.084***
(0.007) (0.007) (0.012) (0.012)
(Total Debt/Total Assets)t−1 0.060 0.090 0.006 0.056
(0.070) (0.070) (0.112) (0.110)
(Cash/Total Assets)t−1 0.183** 0.181** 0.241** 0.244**
(0.077) (0.075) (0.123) (0.120)
Firm-years 1,273 1,284 1,273 1,284
Firm deviations p-value 0.000 0.000 0.000 0.000
Overid p-value 0.245 0.138 0.309 0.196
Notes: Average marginal effects of the regressors on the expected value of the
censored dependent variable are reported. The HHI Sales Diversification and
Entropy Sales Diversification measures are the dependent variables. R&D/TA, is the
ratio of R&D expenditures to total assets. Foreign Productive Assets is a dummy variable
equal to one if a firm reports ownership of foreign productive assets and zero otherwise.
New Equity/Total Assets is the ratio of new equity issue to total assets. log(Employment)
is the natural logarithm of the number of employees. Total Debt/Total Assets is the ratio
of total debt to total assets. Cash/Total Assets is the ratio of cash and equivalents to
total assets. Firm deviations is the test of joint significance of industry dummy variables
interacted with panel data forecast errors (p-value reported). Cluster-robust standard errors
(by firm) in parentheses. * p≤ 0.10, ** p≤ 0.05, *** p≤ 0.01. A constant, time dummy
variables, and panel data forecast errors (firm–industry median deviations) interacted with
industry dummy variables are included but not reported in specifications 1 and 2 (3 and 4).
Overid is the test of overidentifying restrictions, p-value reported.
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Table 7: IV Tobit Results, five regions.
Panel Data Firm–Industry
Forecast Errors Median Deviations
(1) (2) (3) (4)
HHI Sales Diversificationt−1 0.020*** 0.018***
(5 regions) (0.006) (0.006)
Entropy Sales Diversificationt−1 0.026*** 0.024***
(5 regions) (0.008) (0.008)
Foreign Productive Assetst−1 0.003 0.003 0.004 0.004
(0.002) (0.002) (0.002) (0.002)
(New Equity/Total Assets)t−1 0.018** 0.017** 0.018** 0.018**
(0.009) (0.009) (0.008) (0.008)
Log(Employment)t−1 0.001** 0.001** 0.001** 0.001*
(0.001) (0.001) (0.001) (0.001)
(Total Debt/Total Assets)t−1 -0.013** -0.012* -0.011 -0.010
(0.007) (0.007) (0.007) (0.007)
(Cash/Total Assets)t−1 0.023* 0.024* 0.024* 0.025**
(0.012) (0.012) (0.012) (0.012)
Firm-years 1,980 1,980 2,001 2,001
Firm deviations p-value 0.000 0.000 0.000 0.000
Overid p-value 0.140 0.234 0.083 0.149
Notes: Average marginal effects of the regressors on the expected value of the cen-
sored dependent variable are reported. The ratio of R&D expenditures to total assets,
R&D/TA, is the dependent variable. HHI Sales Diversification is one minus sum of
squared shares of sales to five regions of the world. Entropy Sales Diversification is en-
tropy based measure of diversification as discussed in Section 3. Foreign Productive Assets
is a dummy variable equal to one if a firm reports ownership of foreign productive
assets and zero otherwise. New Equity/Total Assets is the ratio of new equity issue
to total assets. log(Employment) is the natural logarithm of the number of employees.
Total Debt/Total Assets is the ratio of total debt to total assets. Cash/Total Assets is the
ratio of cash and equivalents to total assets. Firm deviations is the test of joint significance
of industry dummy variables interacted with panel data forecast errors (p-value reported).
Cluster-robust standard errors (by firm) in parentheses. * p≤ 0.10, ** p≤ 0.05, *** p≤ 0.01.
A constant, time dummy variables, and panel data forecast errors (firm–industry median
deviations) interacted with industry dummy variables are included but not reported in
specifications 1 and 2 (3 and 4). Overid is the test of overidentifying restrictions, p-value
reported.
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